Susan A. Davidson

6.6k total citations · 3 hit papers
57 papers, 2.5k citations indexed

About

Susan A. Davidson is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Susan A. Davidson has authored 57 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Reproductive Medicine, 22 papers in Surgery and 15 papers in Obstetrics and Gynecology. Recurrent topics in Susan A. Davidson's work include Ovarian cancer diagnosis and treatment (26 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Intraperitoneal and Appendiceal Malignancies (12 papers). Susan A. Davidson is often cited by papers focused on Ovarian cancer diagnosis and treatment (26 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Intraperitoneal and Appendiceal Malignancies (12 papers). Susan A. Davidson collaborates with scholars based in United States, Australia and United Kingdom. Susan A. Davidson's co-authors include Mark F. Brady, Paul DiSilvestro, John K. Chan, Robert S. Mannel, Stephen C. Rubin, Joan L. Walker, Kian Behbakht, Helen Huang, Jessica L. Harding and Anna Peeters and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Diabetes Care.

In The Last Decade

Susan A. Davidson

55 papers receiving 2.5k citations

Hit Papers

Inherited Mutations in Women With Ovarian Carcinoma 2015 2026 2018 2022 2015 2017 2016 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inherited Mutations in Women With Ovarian Carcinoma
    2015 503 citations Mark F. Brady, John K. Chan et al. profile →
  2. Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
    2017 406 citations Robert L. Coleman, Mark F. Brady et al. The Lancet Oncology profile →
  3. Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
    2016 250 citations John K. Chan, Mark F. Brady et al. New England Journal of Medicine profile →

Peers

Susan A. Davidson
Ilana Cass United States
Matthew Burnell United Kingdom
Lee-may Chen United States
Susan C. Modesitt United States
David Oram United Kingdom
Patricia L. Judson United States
Mihaela Cristea United States
David Guthrie United Kingdom
Koen De Geest United States
Elena Ratner United States
Ilana Cass United States
Susan A. Davidson
Citations per year, relative to Susan A. Davidson Susan A. Davidson (= 1×) peers Ilana Cass

Countries citing papers authored by Susan A. Davidson

Since Specialization
Citations

This map shows the geographic impact of Susan A. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan A. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan A. Davidson more than expected).

Fields of papers citing papers by Susan A. Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan A. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan A. Davidson. The network helps show where Susan A. Davidson may publish in the future.

Co-authorship network of co-authors of Susan A. Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of Susan A. Davidson. A scholar is included among the top collaborators of Susan A. Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan A. Davidson. Susan A. Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Coleman, Robert L., Mark F. Brady, Thomas J. Herzog, et al.. (2017). Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology. 18(6). 779–791. 406 indexed citations breakdown →
3.
4.
Chan, John K., Mark F. Brady, Richard T. Penson, et al.. (2016). Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer. New England Journal of Medicine. 374(8). 738–748. 250 indexed citations breakdown →
5.
Doo, David W., Saketh R. Guntupalli, Bradley R. Corr, et al.. (2015). Comparative Surgical Outcomes for Endometrial Cancer Patients 65 Years Old or Older Staged With Robotics or Laparotomy. Annals of Surgical Oncology. 22(11). 3687–3694. 15 indexed citations
6.
7.
Guy, Michael S., Georgina Cheng, Monique A. Spillman, et al.. (2014). Outcomes of Women With Atypical Glandular Cells on Preoperative Cytology and Endometrial Cancer. International Journal of Gynecological Cancer. 24(2). 266–271. 5 indexed citations
8.
Carlson, Julie A., Chad G. Rusthoven, Peter E. DeWitt, et al.. (2014). Are We Appropriately Selecting Therapy For Patients With Cervical Cancer? Longitudinal Patterns-of-Care Analysis for Stage IB-IIB Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 90(4). 786–793. 17 indexed citations
9.
Davidson, Susan A., et al.. (2010). Reducing heart disease through the vegetarian diet using primary prevention. Journal of the American Academy of Nurse Practitioners. 22(3). 134–139. 7 indexed citations
10.
Behbakht, Kian, Lubna Qamar, Ricardo D. Coletta, et al.. (2007). Six1 Overexpression in Ovarian Carcinoma Causes Resistance to TRAIL-Mediated Apoptosis and Is Associated with Poor Survival. Cancer Research. 67(7). 3036–3042. 148 indexed citations
11.
Zhang, Zhihong, Meenakshi Singh, Susan A. Davidson, et al.. (2007). Activation of BTAK expression in primary ovarian surface epithelial cells of prophylactic ovaries. Modern Pathology. 20(10). 1078–1084. 11 indexed citations
12.
Spannuth, Whitney A., Charles A. Leath, Warner K. Huh, et al.. (2006). A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy. Gynecologic Oncology. 104(3). 591–595. 17 indexed citations
13.
Davidson, Susan A., et al.. (2004). HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization. International Journal of Gynecological Cancer. 14(6). 1078–1085. 8 indexed citations
14.
Davidson, Susan A., et al.. (2004). Endometrial carcinoma in one horn of a bicornuate uterus. Gynecologic Oncology. 95(3). 729–732. 12 indexed citations
15.
Sloane, Philip D., et al.. (1999). Severe Disruptive Vocalizers. Journal of the American Geriatrics Society. 47(4). 439–445. 32 indexed citations
16.
Wilson, Nancy, et al.. (1997). Management of the Patient With Disruptive Vocalization. The Gerontologist. 37(5). 675–682. 33 indexed citations
17.
Minjarez, Debra A., et al.. (1997). Spontaneous Arterial Thrombosis with an Advanced Ovarian Malignancy. Gynecologic Oncology. 64(1). 176–179. 9 indexed citations
18.
Davidson, Susan A., Stephen C. Rubin, Borys Mychalczak, et al.. (1993). Limited-Field Radiotherapy as Salvage Treatment of Localized Persistent or Recurrent Epithelial Ovarian Cancer. Gynecologic Oncology. 51(3). 349–354. 12 indexed citations
19.
Goldberg, Gary L., et al.. (1992). Lymph node sampling in patients with epithelial ovarian carcinoma. Gynecologic Oncology. 47(2). 143–145. 10 indexed citations
20.
Davidson, Susan A., et al.. (1968). TREATMENT OF LATERAL EPICONDYLITIS. Australian Journal of Physiotherapy. 14(1). 11–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilana Cass Breakdown of academic impact, for papers by Matthew Burnell Breakdown of academic impact, for papers by Lee-may Chen Breakdown of academic impact, for papers by Susan C. Modesitt Breakdown of academic impact, for papers by David Oram Breakdown of academic impact, for papers by Patricia L. Judson Breakdown of academic impact, for papers by Mihaela Cristea Breakdown of academic impact, for papers by David Guthrie Breakdown of academic impact, for papers by Koen De Geest Breakdown of academic impact, for papers by Elena Ratner
Rankless by CCL
2026